|
N.A. Korobkov, N.V. Bakulina, M.V. Maximov
Arterial hypertension in pregnant women: «comorbidity» or a risk factor for postoperative infectious complications?
|
№4-5 / 2023
|
|
N.A. Korobkov, N.V. Bakulina, N.V. Borovik
Metabolic comorbidity of endometritis after caesarean section
|
№3 / 2023
|
|
O.A. Polyakova, Yu.M. Tkachenko, O.D. Ostroumova
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid
|
№1-2 / 2023
|
|
V.S. Nikiforov
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
|
№13 / 2022
|
|
D.I. Trukhan
A comorbid patient at a therapeutic reception during the COVID-19 pandemic. Current aspects of the rehabilitation period
|
№13 / 2022
|
|
T.E. Morozova (1), D.A. Shatskiy (1), T.B. Andruschishina (1), M.V. Lukina (1), V.P. Fisenko (1), D.A. Sychev (2)
Efficacy and tolerability of ketoprofen in patients with coronary artery disease in the postoperative period after cardiac surgery, depending on the comorbid status
|
№3 / 2022
|
|
V.A. Revyakina
From allergic rhinitis to bronchial asthma
|
№1 / 2022
|
|
D.I. Trukhan (1), E.L. Davydov (2)
The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on the rehabilitation stage
|
№13 / 2021
|
|
D.I. Trukhan (1), E.L. Davydov (2)
The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on non-specific prevention
|
№10 / 2021
|
|
N.V. Bagisheva (1), A.V. Mordyk (1), I.A. Viktorova (1), K.I. Nesterova (1), V.V. Goltyapin (2), A.R. Aroyan (1), S.A. Rudenko (3), N.V. Shirinskaya (4)
Factor analysis of medical risk factors for the development of an unfavorable outcome of tuberculosis treatment in comorbid patients
|
№5 / 2021
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), S.V. Batyukina (1), N.L. Lyakhova (3)
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
|
№3 / 2020
|
|
A.P. Pereverzev, O.D. Ostroumova, O.N. Tkacheva
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
|
№4 / 2019
|
Русский
